Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of topical analgesics in the treatment of myofascial pain syndrome
ChiCTR2100054756Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of loxoprofen and flurbiprofen in chronic myofascial pain (CMP) and myofasciitis (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: pain score. Started Dec 2021; status: recruiting.
02
Drugs
loxoprofenflurbiprofen
03
Conditions
chronic myofascial pain (CMP)myofasciitis
Beyond the preview
Go deeper on ChiCTR2100054756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054756.